文献
J-GLOBAL ID:201202253145196801
整理番号:12A1771641
悪性リンパ腫に対して後で自己幹細胞移植を行う大量ラニムスチン(MCNU),カルボプラチン,エトポシドおよびシクロホスファミド(MCVC)療法の安全性と実施可能性
Safety and feasibility of high-dose ranimustine (MCNU), carboplatin, etoposide, and cyclophosphamide (MCVC) therapy followed by autologous stem cell transplantation for malignant lymphoma
著者 (14件):
KAMEOKA Yoshihiro
(Akita Univ. Graduate School of Medicine, Akita, JPN)
,
TAKAHASHI Naoto
(Akita Univ. Graduate School of Medicine, Akita, JPN)
,
ISHIZAWA Kenichi
(Tohoku Univ. Graduate School of Medicine, Sendai, JPN)
,
KATO Yuichi
(Yamagata Univ., Yamagata, JPN)
,
ITO Jugo
(Hirosaki Univ., Hirosaki, JPN)
,
SASAKI Osamu
(Miyagi Cancer Center, Natori, JPN)
,
MURAI Kazunori
(Iwate Medical Univ., Morioka, JPN)
,
NOJI Hideyoshi
(Fukushima Medical Univ., Fukushima, JPN)
,
HIROKAWA Makoto
(Akita Univ., Akita, JPN)
,
TAJIMA Katsusi
(Yamagata Univ., Yamagata, JPN)
,
SHICHISHIMA Tsutomu
(Fukushima Medical Univ., Fukushima, JPN)
,
ISHIDA Yoji
(Iwate Medical Univ., Morioka, JPN)
,
HARIGAE Hideo
(Tohoku Univ. Graduate School of Medicine, Sendai, JPN)
,
SAWADA Kenichi
(Akita Univ. Graduate School of Medicine, Akita, JPN)
資料名:
International Journal of Hematology
(International Journal of Hematology)
巻:
96
号:
5
ページ:
624-630
発行年:
2012年11月
JST資料番号:
F0888A
ISSN:
0925-5710
CODEN:
IJHEEY
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
ドイツ (DEU)
言語:
英語 (EN)